Anal Fissure Treatment Market Report 2026

Anal Fissure Treatment Market Overview

• Anal Fissure Treatment market size has reached to $1.55 billion in 2025 • Expected to grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: The Influence Of Growing Gastrointestinal Disorders On The Anal Fissure Treatment Market • Market Trend: Innovative Solutions For Anal Fissure Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anal Fissure Treatment Market?

Anal fissure treatment refers to healing of small tear in the thin, moist tissue that lines the anus with help of practices like using sitz bath or taking stool softeners. They are used to calm the sphincter muscles and promote healing of the anal fissure. The major types of anal fissure treatments are topical nitroglycerin, calcium channel blockers, stool softeners, and others. Topical nitroglycerin is an ointment used to treat chronic anal fissures and reduce moderate to severe discomfort. This medicine belongs to a member of the nitrate drugs family. Topical and oral are the major routes of administration involved, which are used in several applications, such as clinics, hospitals, and others.

What Is The Anal Fissure Treatment Market Growth Forecast?

The anal fissure treatment market size is expected to see strong growth in the next few years. It will grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing demand for minimally invasive treatments, rising patient preference for home-based care, expansion of specialty colorectal clinics, growing use of combination therapeutic approaches, increasing focus on long-term symptom management. Major trends in the forecast period include increasing use of non-surgical treatment options, rising adoption of topical therapies, growing awareness of early diagnosis and management, expansion of outpatient treatment protocols, enhanced focus on patient comfort and compliance.

Global Anal Fissure Treatment Market Segmentation

1) By Type: Topical Nitroglycerin, Calcium Channel Blockers, Stool Softeners 2) By Route Of Administration: Topical, Oral 3) By End-User: Clinics, Hospitals Subsegments: 1) By Topical Nitroglycerin: 0.2% Nitroglycerin Ointment, 0.4% Nitroglycerin Ointment 2) By Calcium Channel Blockers: Diltiazem Cream, Nifedipine Ointment 3) By Stool Softeners: Docusate Sodium, Polyethylene Glycol (PEG)

What Is The Driver Of The Anal Fissure Treatment Market?

The rising incidence of gastrointestinal disorders is expected to boost the growth of the anal fissure treatment market going forward. Gastrointestinal disorders, also known as digestive disorders, refer to a group of medical conditions that affect the organs and structures of the gastrointestinal (GI) tract. The rising incidence of gastrointestinal disorders creates a parallel increase in the occurrence of anal fissures, driving the demand for effective and targeted treatments within the anal fissure treatment market. For instance, in September 2023, according to the National Library of Medicine, a US-based biomedical library operated by the United States federal government, the overall incidence of Inflammatory Bowel Disease (IBD) in Canada in 2023 is 30 per 100,000, that is 11,000 new diagnoses of Inflammatory Bowel Disease (IBD) were made in 2023. Incidence is projected to rise by 0.58% per year, reaching 32.1 per 100,000 by 2035. Therefore, the rising incidence of gastrointestinal disorders is driving the growth of the rising incidence of the anal fissure treatment industry.

Key Players In The Global Anal Fissure Treatment Market

Major companies operating in the anal fissure treatment market are Abbott Laboratories, GlaxoSmithKline plc, Bayer AG, Pfizer Inc, Taro Pharmaceutical Industries Ltd, Mallinckrodt Pharmaceuticals Limited, Sanofi S.A., Johnson & Johnson Services Inc, Allergan Inc, Valeant Pharmaceuticals International Inc, Purdue Pharma LP, AstraZeneca plc, Eisai Co. Ltd, Geri-care Pharmaceuticals Corp, Taj Pharmaceuticals Limited, Troikaa Pharmaceuticals Ltd, Eli Lilly and Company, Roche Holding AG, AbbVie Inc, Amgen Inc

Global Anal Fissure Treatment Market Trends and Insights

Major companies operating in the anal fissure treatment market are developing innovative products such as anal fissure topical treatments to meet larger customer bases, more sales, and increase revenue. Anal fissure topical treatment refers to the use of medications or ointments that are applied directly to the affected area of an anal fissure. For instance, in July 2023, Acrux Limited, an Australia-based pharmaceutical company, announced the United States Food and Drug Administration (FDA) approval for review of Nitroglycerin Ointment, 0.4%. Nitroglycerin Ointment, 0.4%, stands out for its application in treating moderate to severe pain linked to chronic anal fissures, addressing the discomfort associated with a tear in the anus lining. The company places a primary emphasis on advancing later-stage projects poised for imminent commercialization, while concurrently making strides in the development of earlier-stage products, ensuring a well-rounded and diverse product pipeline.

What Are Latest Mergers And Acquisitions In The Anal Fissure Treatment Market?

In January 2024, Merck KGaA, a Germany-based science and technology company that provides anal fissure treatment partnered with Inspirna Inc. With this partnership, Merck KGaA expanded its colorectal cancer portfolio through a licensing agreement for the drug ompenaclid (RGX-202). This first-in-class oral inhibitor targets the creatine transport channel SLC6A8 and is currently in Phase II development for advanced RAS-mutated colorectal cancer (mCRC). Inspirna Inc. is a US-based clinical-stage biopharmaceutical company.

Regional Outlook

North America was the largest region in the anal fissure treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the anal fissure treatment market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anal Fissure Treatment Market?

The anal fissure treatment market includes revenues earned by entities by providing medications such as ointments and therapies for anal fissure. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anal Fissure Treatment Market Report 2026?

The anal fissure treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anal fissure treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.